Variable Bolus Regimen 1-2-3 for Type 2 Diabetes Mellitus
NCT00135083
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
347
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
insulin glulisine
Sponsor
Sanofi